COMPANY
Avisi
Raises and deals from press releases
- Raise Series A · $10.7M · announced Mar 12, 2026 Company release ↗
Source quote
- Mar 12, 2026 · Company release ↗
“Avisi raises $10.7M to advance study on VisiPlate glaucoma device” - Round · Company release ↗
“announced it has secured $10.7 million in a recent Series A financing round to support the SAPPHIRE pivotal clinical trial”
- Mar 12, 2026 · Company release ↗
Timeline
Upcoming milestones
- 2027-10 (ESTIMATED) · Not phased · Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma · NCT07220876
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07220876 | Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma | Not phased (device or behavioral study) | Recruiting | Nov 7, 2025 | 2027-10 (estimated) |